Caverject

Caverject is a medication containing Alprostadil, used for intracavernous administration. It is commonly associated with erectile dysfunction treatment and is manufactured by Pfizer Luxembourg S.À.R.L.

Caverject, containing the active ingredient Alprostadil, is primarily used to address erectile dysfunction. This medication works by enhancing blood flow to the penis, facilitating an erection. It is administered directly into the penis via injection, making it a targeted treatment option for men experiencing difficulties with achieving or maintaining an erection.

Common effects of Caverject may include mild pain or bruising at the injection site. Some users might experience a temporary warm or tingling sensation. These effects are generally short-lived and should subside quickly. If any severe or persistent effects occur, it is advisable to consult a healthcare professional.

Caverject should be handled with care to avoid contamination. It is important to follow proper injection techniques to minimize the risk of infection or injury. Users should be aware of potential allergic reactions and discontinue use if any severe symptoms, such as difficulty breathing or swelling, occur. Always store the medication as directed to maintain its efficacy.

Caverject may interact with other medications, particularly those that affect blood flow or blood pressure. It is advisable to inform a healthcare provider about all current medications before using Caverject. Alcohol consumption should be moderated, as it may exacerbate the effects of the medication. Additionally, certain foods or supplements that affect blood clotting should be considered.